12 unknown. 12 Phase 2, 4 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Unknown 12 |
| Phase 1 | 4 | Unknown 4 |
| Phase 3 | 4 | Unknown 4 |
Follow Metaplasia: new trials by email Literature Review of Metaplasia trials Research Report on Metaplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin bevacizumab with oral curcumin, bevacizumab with oral placebo - Diabetic Macular Edema, Macular Edema | Phase 2 / Phase 3 | Unknown | Isfahan University of Medical Sciences | 52 | 2021-10-10 | 2024-09-19 |
| The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization KDR2-2 suspension eye drops - Corneal Neovascularization | Phase 1 / Phase 2 | Unknown | Zhongshan Ophthalmic Center, Sun Yat-sen University | 60 | 2021-08-10 | 2021-08-18 |
| Conbercept in Choroidal Neovascularization Secondary to Uveitis Conbercept, sham - Choroidal Neovascularization, Uveitis | Phase 2 | Unknown | Chongqing Medical University | 40 | 2016-11-01 | 2016-10-17 |
| Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection ziv-aflibercept - Neovascularization, Macular Degeneration | Phase 2 | Unknown | Rafic Hariri University Hospital | 100 | 2015-03-01 | 2018-08-29 |
| Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating BM-MNC injection - Lower Extremity Ischemia, Leg Ulcer | Phase 1 / Phase 2 | Unknown | Pontifícia Universidade Católica do Paraná | 60 | 2014-09-01 | 2017-12-13 |
| Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy ranibizumab 2.0mg - Polypoidal Choroidal Vasculopathy | Phase 1 / Phase 2 | Unknown | Retina Consultants of Hawaii | 20 | 2010-11-01 | 2010-11-25 |
| Bevacizumab for the Treatment of Corneal Neovascularization Bevacizumab - Corneal Neovascularization | Phase 2 | Unknown | Chang Gung Memorial Hospital | 10 | 2009-05-01 | 2009-10-15 |
| Treatment for Achilles Tendinopathy 25% Dextrose and 1% Lidocaine, Lidocaine, sclerotherapy - Achilles Tendinopathy, Achilles Tendon Enthesopathy | Phase 2 / Phase 3 | Unknown | University of Calgary | 17 | 2007-09-01 | 2009-02-04 |
| Avastin for CNV Secondary to Pattern Dystrophy intravitreal triamcinolone injection of avastin (1.25 mg) - Choroidal Neovascularization Secondary to Pattern Dystrophy | Phase 2 / Phase 3 | Unknown | University of Trieste | 5 | 2006-07-01 | 2006-10-23 |
| Bevacizumab in Advanced Hepatocellular Carcinoma bevacizumab - Hepatocellular Carcinoma | Phase 2 | Unknown | Gustave Roussy, Cancer Campus, Grand Paris | 50 | 2005-05-01 | 2006-09-08 |
| Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System Ocular Brachytherapy - Macular Degeneration, Choroidal Neovascularization | Phase 1 / Phase 2 | Unknown | Theragenics Corporation | 30 | 2004-10-01 | 2005-06-24 |
| TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration Photodynamic therapy versus Transpupillary thermotherapy - Choroidal Neovascularization | Phase 2 / Phase 3 | Unknown | St. Erik Eye Hospital | 140 | 2003-06-01 | 2006-02-03 |
Choroidal Neovascularization (5) · Neovascularization, Pathologic (4) · Corneal Neovascularization (2) · Diabetic Retinopathy (2) · Macular Degeneration (2) · Macular Edema (2) · Retinal Neovascularization (2) · Carcinoma, Hepatocellular (1) · Diabetic Foot (1) · Gangrene (1) · Leg Ulcer (1) · Peripheral Vascular Diseases (1) · Polypoidal Choroidal Vasculopathy (1) · Pterygium (1) · Retinal Degeneration (1)
Pathologic Processes (12) · Pathological Conditions, Signs and Symptoms (12) · Eye Diseases (9) · Neovascularization, Pathologic (8) · Choroid Diseases (6) · Uveal Diseases (6) · Cardiovascular Diseases (4) · Diabetes Complications (3) · Diabetes Mellitus (3) · Diabetic Angiopathies (3) · Endocrine System Diseases (3) · Vascular Diseases (3) · Corneal Diseases (2) · Retinal Degeneration (2)
Bevacizumab (3) · Curcumin (1) · Glucose (1) · KH902 fusion protein (1) · Lidocaine (1) · Ranibizumab (1) · Sclerotherapy (1) · aflibercept (1) · salicylhydroxamic acid (1)
Chang Gung Memorial Hospital (1) · Chongqing Medical University (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Isfahan University of Medical Sciences (1) · Pontifícia Universidade Católica do Paraná (1) · Rafic Hariri University Hospital (1) · Retina Consultants of Hawaii (1) · St. Erik Eye Hospital (1) · Theragenics Corporation (1) · University of Calgary (1) · University of Trieste (1) · Zhongshan Ophthalmic Center, Sun Yat-sen University (1)
United States (2) · Brazil (1) · Canada (1) · China (1) · France (1) · Iran (1) · Italy (1) · Lebanon (1) · Sweden (1) · Taiwan (1)
Ahmad M Mansour, MD (1) · Anne C Odergren, MD (1) · Ching-Hsi Hsiao, MD (1) · Giuseppe Ravalico, MD (1) · Gregg T Kokame, MD, MMM (1) · J Preston Wiley, MD, MPE (1) · Maurizio B Parodi, MD (1) · Paulo Brofman, PhD (1) · Pierluigi Iacono, MD (1) · Stefan Seregard, Professor (1)
PMID 11071039, PMID 11741106, PMID 12707595, PMID 16765697, PMID 20375343, PMID 22707516, PMID 25677668, PMID 27030277, PMID 28614154, PMID 31956432, PMID 8720722